Atlas Trials

Effect of Adjuvant Therapy by Sorafenib, Oxaliplatin and S-1

Clinical trial NCT02129322 · WITHDRAWN

Trial details

NCT number
NCT02129322
Sponsor
Zhejiang University
Status
WITHDRAWN
Phase
Phase 2
Study type
INTERVENTIONAL
Hepatocellular Carcinoma
Start date
2015-07-01
Primary completion
2017-06-01
Enrollment
0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.